High quality raw material for IVD manufacturing industry

Recombinant capsid antigen p18 for Epstein-barr virus

Epstein-barr virus
p18 is an antigen of 18 kDa codified by the BFRF3 gene. Antibody to VCA are found both in early and late EBV infection. At the time of infection, antibody of both the IgM and IgG types are detectable. After four to six months, usually, only the IgG antibody against VCA can be found. VCA-p18 can be considered to be the best dominant immunoreactive antigen for use in IgM VCA diagnosis (Wout et al., 1993, J. of Virology, p. 3908-3916).
REFERENCES
RAG0049 WB, DB, Indirect ELISA, positive control in direct ELISA, CLIA
GENE
BFRF3
DESCRIPTION
Viral capsid antigen
PURITY
>98% in a SDS-PAGE
SHIPPING AND STORAGE CONDITIONS
Proteins will be shipped on dry ice or ice pack. Upon arrival they should be stored at -20ºC to -80ºC. Avoid multiple freeze/thaw cycles
STABILITY
The protein will remain stable for four years if stored frozen
SPECIFICITY
The protein is immunoreactive against seropositive individuals to Epstein-Barr virus infection
IVD
Serodiagnosis of infectious mononucleosis associated to EBV and primary acute infections in immunocompromised individuals
SATISFACTION GUARANTEE
86% success rate in evaluations of recombinant antigen p18 (RAG0049) for the development of a diagnostic assay
RELATED PRODUCTS

FOR RESEARCH USE ONLY

RETURN TO RECOMBINANT ANTIGENS